We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.08B
AUM Growth
+$312M
(+4.6%)
Cap. Flow
+$423M
Cap. Flow
% of AUM
5.97%
Top 10 Holdings %
Top 10 Hldgs %
31.95%
Holding
1,367
New
348
Increased
332
Reduced
294
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$188M |
| 2 |
Labcorp
LH
|
+$183M |
| 3 |
AGN
Allergan Inc
AGN
|
+$144M |
| 4 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$93.8M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$82.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brookdale Senior Living
BKD
|
+$104M |
| 2 |
Cardinal Health
CAH
|
+$104M |
| 3 |
AGN
Allergan plc
AGN
|
+$80.7M |
| 4 |
AMAG
AMAG Pharmaceuticals
AMAG
|
+$60.3M |
| 5 |
Elevance Health
ELV
|
+$55.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 47.3% |
| 2 | Consumer Discretionary | 5.38% |
| 3 | Financials | 4.49% |
| 4 | Industrials | 3.37% |
| 5 | Technology | 2.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BBBY
901
DELISTED
Bed Bath & Beyond Inc
BBBY
| $250K | ﹤0.01% |
+3,270
| New | +$228K |
|
902
United Natural Foods
UNFI
$3.08B
| $248K | ﹤0.01% |
+3,199
| New | +$226K |
|
|
AWAY
903
DELISTED
HOMEAWAY INC COM
AWAY
| $246K | ﹤0.01% |
8,259
-21,741
| -72% | -$686K |
|
904
GE Aerospace
GE
$374B
| $245K | ﹤0.01% |
2,018
-12,405
| -86% | -$1.53M |
|
905
CNO Financial Group
CNO
$5.14B
| $244K | ﹤0.01% |
+14,130
| New | +$243K |
|
906
Emcor
EME
$35.2B
| $244K | ﹤0.01% |
+5,473
| New | +$235K |
|
907
World Kinect Corp
WKC
$2.04B
| $244K | ﹤0.01% |
+5,196
| New | +$225K |
|
|
CSOD
908
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $244K | ﹤0.01% |
+6,911
| New | +$228K |
|
909
Bristol-Myers Squibb
BMY
$133B
| $243K | ﹤0.01% |
+4,100
| New | +$231K |
|
910
Equifax
EFX
$20.3B
| $243K | ﹤0.01% |
+2,993
| New | +$232K |
|
911
Group 1 Automotive
GPI
$3.41B
| $242K | ﹤0.01% |
+2,690
| New | +$226K |
|
912
ArcBest
ARCB
$3.23B
| $241K | ﹤0.01% |
5,180
-77,459
| -94% | -$3.14M |
|
913
United Bankshares
UBSI
$6.63B
| $241K | ﹤0.01% |
+6,409
| New | +$220K |
|
914
Brink's
BCO
$4.88B
| $240K | ﹤0.01% |
9,800
-2,800
| -22% | -$62.7K |
|
915
Las Vegas Sands
LVS
$31.7B
| $240K | ﹤0.01% |
+4,115
| New | +$248K |
|
916
ScottsMiracle-Gro
SMG
$3.82B
| $240K | ﹤0.01% |
+3,840
| New | +$229K |
|
917
MasTec
MTZ
$20.8B
| $239K | ﹤0.01% |
10,540
-483,376
| -98% | -$12M |
|
918
Thor Industries
THO
$3.9B
| $238K | ﹤0.01% |
+4,250
| New | +$229K |
|
|
DYAX
919
DELISTED
DYAX CORPORATION
DYAX
| $236K | ﹤0.01% |
+16,736
| New | +$209K |
|
920
Microchip Technology
MCHP
$40.3B
| $235K | ﹤0.01% |
10,398
-12,722
| -55% | -$277K |
|
921
Kennametal
KMT
$2.59B
| $234K | ﹤0.01% |
+6,530
| New | +$249K |
|
|
SLCA
922
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $233K | ﹤0.01% |
+9,050
| New | +$357K |
|
|
VR
923
DELISTED
Validus Hold Ltd
VR
| $233K | ﹤0.01% |
+5,600
| New | +$226K |
|
924
KBR
KBR
$4.64B
| $232K | ﹤0.01% |
13,657
-16,546
| -55% | -$297K |
|
925
Annaly Capital Management
NLY
$17.1B
| $232K | ﹤0.01% |
+5,343
| New | +$242K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q4 2014 Portfolio in Review
As of Q4 2014, Visium Asset Management held 1,367 positions worth $7.08B, up 4.6% from $6.77B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Visium Asset Management deployed $423M of net new capital in Q4 2014, opening 348 new positions and adding to 332 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 988,391 shares worth $89.4M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Brookdale Senior Living, an estimated $104M trimmed.
- Visium Asset Management's largest Q4 2014 buy was BioMarin Pharmaceuticals: 988,391 shares worth $89.4M.
- Visium Asset Management added most to COVIDIEN PLC COM SHS NEW (IRELAND) in Q4 2014, an estimated $188M increase.
- Visium Asset Management's biggest Q4 2014 reduction was Brookdale Senior Living, cutting an estimated $104M.
- Visium Asset Management fully exited AMAG Pharmaceuticals in Q4 2014, selling an estimated $60.3M.
- Visium Asset Management's ten largest holdings make up 32% of its $7.08B portfolio in Q4 2014.
- Visium Asset Management opened 348 new positions and closed 358 in Q4 2014.
- Visium Asset Management's portfolio value rose 4.6% quarter-over-quarter to $7.08B.
Based on Visium Asset Management's 13F filing for Q4 2014, filed 13 Feb 2015.